Ferraz Oliveira, RitaAfreixo, VeraSantos, JoãoMota, PriscillaCruz, AgostinhoPimentel, Francisco2019-07-182019-07-182017Oliveira, R., Afreixo, V., Santos, J., Mota, P., Cruz, A., & Pimentel, F. (2016). Polypharmacy in older patients with cancer. Proceedings of the 3rd IPLeiria’s International Health Congress - BMC Health Services Research, 16 (3), 86.http://hdl.handle.net/10400.22/14455Polypharmacy is associated with drug–drug interactions, adverse drug events, hospitalization, increased mortality and rising costs. Older cancer patients are potentially vulnerable to polypharmacy because cancer treatment often involves exposure to chemotherapy and other adjunctive or supportive medication.engElderly patientsOlder patientsPolypharmacyCancerChemotherapyconference object